Statistics

Total Visits

Views
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 572

Total Visits per Month

October 2017 November 2017 December 2017 January 2018 February 2018 March 2018 April 2018
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 1 0 1 1 1 0 1

File Downloads

Views
4403[1].pdf 222

Top Country Views

Views
United States 282
Russia 89
Poland 53
Denmark 26
Canada 23
China 22
United Kingdom 13
Germany 11
France 6
South Korea 4

Top City Views

Views
Minneapolis 120
Spartanburg 67
Houston 31
Miami Beach 16
Toronto 14
Zhengzhou 6
Beijing 5
San Jose 5
Brighton 4
Nynäs 4